403 related articles for article (PubMed ID: 22949344)
1. The role of aldosterone receptor antagonists in the management of heart failure: an update.
Nagarajan V; Chamsi-Pasha M; Tang WH
Cleve Clin J Med; 2012 Sep; 79(9):631-9. PubMed ID: 22949344
[TBL] [Abstract][Full Text] [Related]
2. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone antagonists in heart failure.
Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
[TBL] [Abstract][Full Text] [Related]
4. Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
Kalidindi SR; Tang WH; Francis GS
Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):368-78. PubMed ID: 17589427
[TBL] [Abstract][Full Text] [Related]
5. Eplerenone in the treatment of chronic heart failure.
Krum H; Liew D
Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479
[TBL] [Abstract][Full Text] [Related]
6. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
[TBL] [Abstract][Full Text] [Related]
7. [Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure].
Tereshchenko SN; Zhirov IV; Osmolovskaia IuF
Ter Arkh; 2013; 85(12):137-43. PubMed ID: 24640683
[TBL] [Abstract][Full Text] [Related]
8. The role of aldosterone and aldosterone-receptor antagonists in heart failure.
Khan NU; Movahed A
Rev Cardiovasc Med; 2004; 5(2):71-81. PubMed ID: 15184841
[TBL] [Abstract][Full Text] [Related]
9. New treatment option for heart failure patients: eplerenone.
Southworth MR; Cavallari LH
J Cardiovasc Nurs; 2004; 19(6):390-5. PubMed ID: 15529060
[TBL] [Abstract][Full Text] [Related]
10. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
Dawson A; Davies JI; Struthers AD
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
[TBL] [Abstract][Full Text] [Related]
12. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.
Barnes BJ; Howard PA
Ann Pharmacother; 2005 Jan; 39(1):68-76. PubMed ID: 15590870
[TBL] [Abstract][Full Text] [Related]
13. Blocking aldosterone in heart failure.
Shafiq MM; Miller AB
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone is not superior to older and less expensive aldosterone antagonists.
Chatterjee S; Moeller C; Shah N; Bolorunduro O; Lichstein E; Moskovits N; Mukherjee D
Am J Med; 2012 Aug; 125(8):817-25. PubMed ID: 22840667
[TBL] [Abstract][Full Text] [Related]
15. Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure.
Iqbal J; Parviz Y; Pitt B; Newell-Price J; Al-Mohammad A; Zannad F
Eur J Heart Fail; 2014 Feb; 16(2):143-50. PubMed ID: 24464876
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
[TBL] [Abstract][Full Text] [Related]
17. Adherence to aldosterone-blocking agents in patients with heart failure.
Margolis J; Gerber RA; Roberts C; Gheorghiade M
Am J Ther; 2010; 17(5):446-54. PubMed ID: 20844344
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
Thohan V; Torre-Amione G; Koerner MM
Curr Opin Cardiol; 2004 Jul; 19(4):301-8. PubMed ID: 15218387
[TBL] [Abstract][Full Text] [Related]
19. New therapy update. Inspra (eplerenone tablets).
Kloner RA
Congest Heart Fail; 2003; 9(6):341-2. PubMed ID: 14688507
[No Abstract] [Full Text] [Related]
20. Aldosterone receptor antagonists in the medical management of chronic heart failure.
Tang WH; Parameswaran AC; Maroo AP; Francis GS
Mayo Clin Proc; 2005 Dec; 80(12):1623-30. PubMed ID: 16342656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]